Innoviva Inc
NASDAQ:INVA

Watchlist Manager
Innoviva Inc Logo
Innoviva Inc
NASDAQ:INVA
Watchlist
Price: 19.24 USD -3.8% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Innoviva Inc?
Write Note

Innoviva Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innoviva Inc
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Innoviva Inc
NASDAQ:INVA
Capital Expenditures
-$381k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
46%
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
-$4.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
-$1.2B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
-$3.2B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
-$3.4B
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
-$8.3B
CAGR 3-Years
-53%
CAGR 5-Years
-38%
CAGR 10-Years
-18%

See Also

What is Innoviva Inc's Capital Expenditures?
Capital Expenditures
-381k USD

Based on the financial report for Sep 30, 2024, Innoviva Inc's Capital Expenditures amounts to -381k USD.

What is Innoviva Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
46%

Over the last year, the Capital Expenditures growth was 5%.

Back to Top